Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 1 (1)

Trial Status

Active Not Recruiting1
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03947619Not ApplicableActive Not RecruitingPrimary

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

NCT06836661Not ApplicableNot Yet RecruitingPrimary

Impact, Cost, and Sustainability of a Customized, Low-Cost Intervention to Reduce Cardiovascular Disease Burden in India: A Cluster Randomized Trial

NCT02071602Phase 1CompletedPrimary

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

Showing all 3 trials

Research Network

Activity Timeline